BR0113661A - Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2 - Google Patents
Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2Info
- Publication number
- BR0113661A BR0113661A BR0113661-5A BR0113661A BR0113661A BR 0113661 A BR0113661 A BR 0113661A BR 0113661 A BR0113661 A BR 0113661A BR 0113661 A BR0113661 A BR 0113661A
- Authority
- BR
- Brazil
- Prior art keywords
- cyclooxygenase
- pharmaceutical compositions
- enzyme inhibitors
- topical release
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"COMPOSIçõES FARMACêUTICAS PARA A LIBERAçãO TóPICA DE INIBIDORES DA ENZIMA CICLOOXIGENASE-2". A presente invenção refere-se a uma composição farmacêutica para liberação tópica compreendendo uma quantidade efetiva de uma droga que atua seletivamente como inibidora da enzima ciclooxigenase-2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN779DE2000 IN191090B (pt) | 2000-08-29 | 2000-08-29 | |
PCT/IB2001/001557 WO2002017923A1 (en) | 2000-08-29 | 2001-08-28 | Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0113661A true BR0113661A (pt) | 2004-07-06 |
Family
ID=11097085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0113661-5A BR0113661A (pt) | 2000-08-29 | 2001-08-28 | Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040029946A1 (pt) |
EP (1) | EP1315500A4 (pt) |
JP (1) | JP2004525859A (pt) |
CN (1) | CN1227012C (pt) |
AU (1) | AU2001284321A1 (pt) |
BR (1) | BR0113661A (pt) |
CA (1) | CA2420804A1 (pt) |
CZ (1) | CZ2003822A3 (pt) |
IN (1) | IN191090B (pt) |
RU (1) | RU2003108335A (pt) |
SK (1) | SK3622003A3 (pt) |
WO (1) | WO2002017923A1 (pt) |
ZA (1) | ZA200301680B (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US20030105144A1 (en) | 2001-04-17 | 2003-06-05 | Ping Gao | Stabilized oral pharmaceutical composition |
CA2448627A1 (en) * | 2001-05-31 | 2002-12-05 | Pharmacia Corporation | Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol |
US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
US6830744B2 (en) * | 2002-05-31 | 2004-12-14 | Aradigm Corporation | Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
CA2489984A1 (en) * | 2002-06-21 | 2003-12-31 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
AUPS317102A0 (en) * | 2002-06-25 | 2002-07-18 | Drug Delivery Solutions Pty Ltd | Transdermal aerosol compositions |
AU2003238543B2 (en) * | 2002-06-25 | 2008-02-28 | Acrux Dds Pty Ltd | Transdermal aerosol compositions |
EA009024B1 (ru) * | 2002-06-25 | 2007-10-26 | АКРУКС ДиДиЭс ПиТиУай ЭлТиДи | Фармацевтическая композиция для чрескожной доставки активного агента (варианты) |
JP4283507B2 (ja) * | 2002-08-02 | 2009-06-24 | 久光製薬株式会社 | 経皮投与用貼付剤 |
US8183290B2 (en) * | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
JP2007522077A (ja) * | 2003-08-21 | 2007-08-09 | アクセス ファーマシューティカルズ, インコーポレイテッド | 粘膜の疾患および障害の予防および処置のための液体製剤 |
EP1682060A1 (en) * | 2003-10-14 | 2006-07-26 | Dermatrends, Inc. | Enhancing transdermal administration of hydrophilic drugs |
FR2894811B1 (fr) † | 2005-12-21 | 2008-02-22 | Oreal | Composition cosmetique a effet volumateur |
US20070196301A1 (en) * | 2005-12-21 | 2007-08-23 | L'oreal | Cosmetic composition with a volumizing effect |
HU227970B1 (en) * | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
MX2007009796A (es) * | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
WO2012092389A2 (en) * | 2010-12-28 | 2012-07-05 | Mary Kay Inc. | Sebum control and anti-acne composition |
MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
US10045965B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US10045935B2 (en) * | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
MX356551B (es) | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
JP6495723B2 (ja) * | 2015-04-14 | 2019-04-03 | 帝國製薬株式会社 | セレコキシブの経皮吸収製剤 |
CN105663032A (zh) * | 2016-02-23 | 2016-06-15 | 青岛科技大学 | 一种维他昔布软膏剂的制备方法 |
CN107158407A (zh) * | 2017-06-17 | 2017-09-15 | 安徽仁之堂药业有限公司 | 一种中药提取所得挥发油的制剂助剂 |
MX366086B (es) | 2017-08-15 | 2019-06-27 | Cell Therapy And Tech S A De C V | Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2075837B (en) * | 1980-05-14 | 1984-03-14 | Hisamitsu Pharmaceutical Co | Topical pharmaceutical gel containing anti-inflammatory analgesic agents |
US4602040A (en) * | 1983-04-18 | 1986-07-22 | Warner-Lambert Company | Meclofenamic acid topical pharmaceutical composition |
US5093133A (en) * | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
US5807568A (en) * | 1994-12-27 | 1998-09-15 | Mcneil-Ppc, Inc. | Enhanced delivery of topical compositions containing flurbiprofen |
RU2200158C2 (ru) * | 1995-02-13 | 2003-03-10 | Джи.Ди.Сирл энд Ко. | Замещенные изоксазолы, фармацевтические композиции на их основе и способ подавления воспалений |
US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP0863134A1 (en) * | 1997-03-07 | 1998-09-09 | Merck Frosst Canada Inc. | 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2 |
US5976566A (en) * | 1997-08-29 | 1999-11-02 | Macrochem Corporation | Non-steroidal antiinflammtory drug formulations for topical application to the skin |
SE9703693D0 (sv) * | 1997-10-10 | 1997-10-10 | Astra Pharma Prod | Novel combination |
US5998487A (en) * | 1998-04-08 | 1999-12-07 | Colgate-Palmolive Company | Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions |
GB2340751B (en) * | 1998-08-12 | 2003-11-05 | Edko Trading Representation | Pharmaceutical compositions |
SA99191255B1 (ar) * | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
WO2000072883A2 (en) * | 1999-06-02 | 2000-12-07 | Aviana Biopharm | Pharmaceutical transdermal compositions |
IN191512B (pt) * | 2000-01-21 | 2003-12-06 | Panacea Biotech |
-
2000
- 2000-08-29 IN IN779DE2000 patent/IN191090B/en unknown
-
2001
- 2001-08-28 RU RU2003108335/15A patent/RU2003108335A/ru not_active Application Discontinuation
- 2001-08-28 SK SK362-2003A patent/SK3622003A3/sk unknown
- 2001-08-28 WO PCT/IB2001/001557 patent/WO2002017923A1/en not_active Application Discontinuation
- 2001-08-28 AU AU2001284321A patent/AU2001284321A1/en not_active Abandoned
- 2001-08-28 EP EP01963295A patent/EP1315500A4/en not_active Withdrawn
- 2001-08-28 CN CNB018172873A patent/CN1227012C/zh not_active Expired - Fee Related
- 2001-08-28 CZ CZ2003822A patent/CZ2003822A3/cs unknown
- 2001-08-28 BR BR0113661-5A patent/BR0113661A/pt not_active IP Right Cessation
- 2001-08-28 JP JP2002522896A patent/JP2004525859A/ja active Pending
- 2001-08-28 US US10/363,326 patent/US20040029946A1/en not_active Abandoned
- 2001-08-28 CA CA002420804A patent/CA2420804A1/en not_active Abandoned
-
2003
- 2003-02-28 ZA ZA200301680A patent/ZA200301680B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20040029946A1 (en) | 2004-02-12 |
CZ2003822A3 (cs) | 2003-08-13 |
IN191090B (pt) | 2003-09-20 |
CA2420804A1 (en) | 2002-03-07 |
EP1315500A4 (en) | 2006-05-31 |
JP2004525859A (ja) | 2004-08-26 |
SK3622003A3 (en) | 2003-09-11 |
EP1315500A1 (en) | 2003-06-04 |
ZA200301680B (en) | 2004-06-23 |
RU2003108335A (ru) | 2004-09-10 |
WO2002017923A1 (en) | 2002-03-07 |
CN1227012C (zh) | 2005-11-16 |
CN1469748A (zh) | 2004-01-21 |
AU2001284321A1 (en) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0113661A (pt) | Composições farmacêuticas para a liberação tópica de inibidores da enzima ciclooxigenase-2 | |
GT200100152A (es) | Nueva composicion farmaceutica para el tratamiento de la obesidad. | |
BRPI0507972A (pt) | composto ,composição farmacêutica , uso de um composto, método para inibição da atividade proteolìtica de uma enzima de clivagem pós prolina e composição farmacêutica embalada | |
BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
HN2001000146A (es) | Derivados de pirazol | |
BR0009564A (pt) | Utilização de inibidores da cyp2d6 em terapias de combinação | |
BR0115411A (pt) | Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares | |
GT200500137A (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis. | |
CR11106A (es) | Inhibidores de cinasa p710 s6 | |
GT200600194A (es) | Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada | |
UY31046A1 (es) | Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones | |
CR7956A (es) | Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos | |
BRPI0620229B8 (pt) | formulações farmaceuticas e processos de produção da ditas formulações | |
DK1105114T3 (da) | Nimesulidholdige topiske farmaceutiske sammensætninger | |
BR0312921A (pt) | Composição compreendendo inibidor de reductase hmg-coa | |
BR0208813A (pt) | Composições contendo imidazotriazinona para a aplicação nasal | |
HN2000000060A (es) | Composiciones solidad que contienen gabapentina y proceso para su preparacion. | |
BRPI0414822A (pt) | método de inibir a produção de lipoproteìna remanescente | |
UY27610A1 (es) | Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos | |
BRPI0408848A (pt) | formulações orais de cladribine | |
PA8571901A1 (es) | Nueva composicion farmaceutica | |
ES2192263T3 (es) | Derivados de benzo(c)quinolizina, su preparacion y empleo como inhibidores de 5-alfa-reductasas. | |
PA8547801A1 (es) | Microcápsula para la protección frente al mal aliento | |
NO983511D0 (no) | Difenylstilbener som pro-legemidler for COX-2-inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A, 6A E 7A ANUIDADE |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008. |